VAERS Explorer
Back to explore

Report #2880100

Received Dec 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
68 yrs
State
VA
Recovered
Unknown
Vaccinated
Dec 8, 2021
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH3FJ8757—

Symptoms (2)

COVID-19Drug ineffective

Symptom narrative

I have received 3 vaccines and in a short time 3 covid sickness; I have received 3 vaccines and in a short time 3 covid sickness; This is a spontaneous report and received from Consumer or other non HCPs from product quality group. A 72-year-old female patient received BNT162b2 (BNT162B2), on 08Dec2021 as dose 3 (booster), single (Lot number: FJ8757, Expiration Date: 31May2022) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot Number: EP6955), administration date: 27Mar2021, when the patient was 67-year-old, for Covid-19 immunization, reaction(s): "Drug ineffective", "Covid-19"; BNT162b2 (DOSE 2, SINGLE, Lot Number: ER8735), administration date: 27Apr2021, when the patient was 67-year-old, for Covid-19 immunization, reaction(s): "Drug ineffective", "Covid-19". The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "I have received 3 vaccines and in a short time 3 covid sickness". Additional information: Investigation Summary and Conclusion: The complaint for lack of effect of the PFIZER-BIONTECH COVID-19 VACCINE lot FJ8757 was investigated. The investigation included a review of manufacturing and packaging batch records, deviation investigations, and an analysis of complaint history for the reported lot. The final scope included the reported finished goods lot FJ8757, fill lot FJ1608, and formulated drug product lot FK2442. A complaint sample was not returned. No related quality issues were identified during the investigation. There is no impact to product quality. No root cause or corrective/preventative actions were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications.